Phase I Pilot Study Eval Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy
Trial ID or NCT#
Status
Purpose
This randomized, pilot phase I trial studies whether phone or email reminders increases vaginal dilator use in patients with endometrial, cervical, or vaginal cancers after they undergo brachytherapy. Brachytherapy is a type of internal radiation which uses radioactive material placed directly into or near a tumor to kill tumor cells. A reminder program may help increase use of vaginal dilators and decrease long-term side effects following brachytherapy.
Official Title
Phase I Pilot Study Evaluating Vaginal Dilator Use and Toxicity Following Vaginal Brachytherapy
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Dylann Fujimoto
650-723-8843
View on ClinicalTrials.gov